MANILA, Philippines — Pharmaceutical company Sanofi Pasteur allayed parents’ fears over the dengue vaccine injected to more than 7,000 children across the country.
“There are no cases of dengue shock syndrome. There are no reported deaths. All cases of severe dengue have been resolved spontaneously,” said Sanofi Pasteur Regional Director Dr. Joselito Sta. Ana.
The manufacturer belied allegations that there are three children who died after receiving Dengvaxia vaccine.
The Department of Health (DOH) also confirmed that there are no reported fatalities due to Dengvaxia.
“In fact, just for the information of the group, the severe dengue cases they are referring to, among those identified by Sanofi, none of them died. These cases stayed in the hospital for… and their range of stay was four to six days and eventually, they were discharged, and their conditions improved,” said DOH Asec. Lydon Lee Suy.
However, Sanofi admitted that the vaccine will have a negative effect on anyone who received it prior to dengue infection.
“We do see an increased risk of dengue hospitalization and severe dengue in those who have not been previously infected this risk is seen predominantly starting from the 3rd year from the first dose,” said Sanofi Pasteur Global Medical head Dr. Ng Su Peing.
Sanofi explained that nine of the ten children who received Dengvaxia vaccine contracted dengue.
It says the parents are just not aware since the symptoms of the disease are not obvious. The company further said three of four children who received the vaccine did not show any symptoms of the viral infection. It also explains that anyone who has Dengvaxia injection will not automatically have severe dengue.
“You contract [severe dengue] if you had subsequent exposure to the virus, not because you were given the vaccine that you’ll have severe dengue,” said Sanofi Pasteur General Manager Ching Santos.
it does not mean that when you received the vaccine, you will immediately have a severe dengue,”
Amid the controversy, Dengvaxia is believed to be 100 percent effective in children who received the vaccine three times. However, Sanofi advised the parents to not complete for now the injection of the vaccine pending the statement of the World Health Organization regarding the matter. The manufacturer, meanwhile, vows to cooperate with the investigation the NBI will conduct in connection with the issue. — Mon Jocson | UNTV News & Rescue